Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases
Sign Up to like & getrecommendations! Published in 2018 at "Journal for Immunotherapy of Cancer"
DOI: 10.1186/s40425-018-0393-z
Abstract: BackgroundPD-1 and CTLA-4 inhibitors are associated with several adverse events including a spectrum of immune-related adverse effects (irAEs). Neurologic irAEs are uncommon occurrences with varied presentations. We describe two separate cases of ipilimumab associated meningoencephalomyelitis… read more here.
Keywords: immune related; neurologic immune; related adverse; events associated ... See more keywords